First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 162.35 USD -2.95% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Pre-Tax Income Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$6.3B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$6.9B
CAGR 3-Years
60%
CAGR 5-Years
-3%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Moderna Inc
NASDAQ:MRNA
Pre-Tax Income
-$3.9B
CAGR 3-Years
-74%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.4B
CAGR 3-Years
12%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4.2B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
19%

See Also

What is Abbvie Inc's Pre-Tax Income?
Pre-Tax Income
6.3B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Pre-Tax Income amounts to 6.3B USD.

What is Abbvie Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
2%

Over the last year, the Pre-Tax Income growth was -54%. The average annual Pre-Tax Income growth rates for Abbvie Inc have been 23% over the past three years , 4% over the past five years , and 2% over the past ten years .